Debra Tompson
Impact in
- Developmental Neuroscience top 10%
-
- interferon and immune responses
- Phagocytosis and Immune Regulation
Papers in
-
- Epilepsy research and treatment 3
-
- Ion channel regulation and function 1
- Co-authors
- Christopher Crean (7 shared papers)Nicola Scott (4 shared papers)Kathleen Weisel (3 shared papers)Paul P. Tak (3 shared papers)Scott B. Berger (3 shared papers)Sarah A. Job (2 shared papers)Florian Then Bergh (1 shared paper)Richard Grove (1 shared paper)
- Journals
- Current Clinical Pharmacology (3 papers)Clinical Therapeutics (3 papers)British Journal of Clinical Pharmacology (2 papers)Pharmaceutical Research (2 papers)Epilepsia (1 paper)
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
Debra Tompson
28 papers receiving 808 citations
Peers
Comparison fields: 5 of 88
- Developmental Neuroscience 42
- Immunology 184
- Psychiatry and Mental health 104
- Neurology 76
- Molecular Biology 373
Countries citing papers authored by Debra Tompson
This map shows the geographic impact of Debra Tompson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Debra Tompson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Debra Tompson more than expected).
Fields of papers citing papers by Debra Tompson
This network shows the impact of papers produced by Debra Tompson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Debra Tompson. The network helps show where Debra Tompson may publish in the future.
Co-authors
The 25 scholars most cited alongside Debra Tompson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 109 | |
| 2 | 2008 | 90 | |
| 3 | 2016 | 90 | |
| 4 | 1997 | 73 | |
| 5 | 2021 | 69 | |
| 6 | 2021 | 66 | |
| 7 | 2020 | 62 | |
| 8 | 2007 | 57 | |
| 9 | 2007 | 40 | |
| 10 | 2008 | 26 | |
| 11 | 1997 | 23 | |
| 12 | 2013 | 22 | |
| 13 | 2020 | 19 | |
| 14 | 2013 | 15 | |
| 15 | 2013 | 11 | |
| 16 | 2021 | 10 | |
| 17 | 2022 | 10 | |
| 18 | 2014 | 10 | |
| 19 | 2024 | 9 | |
| 20 | 2014 | 8 |
About Debra Tompson
Debra Tompson is a scholar working on Psychiatry and Mental health, Molecular Biology, Oncology, Neurology and Immunology, having authored 28 papers that have together received 849 indexed citations. Recurring topics across this work include Epilepsy research and treatment (3 papers), NF-κB Signaling Pathways (2 papers), Cytokine Signaling Pathways and Interactions (2 papers), Parkinson's Disease Mechanisms and Treatments (2 papers), Pharmacogenetics and Drug Metabolism (1 paper), Chronic Myeloid Leukemia Treatments (1 paper), Neurogenesis and neuroplasticity mechanisms (1 paper) and Ion channel regulation and function (1 paper). The work is most often cited by research in Developmental Neuroscience (42 citations), Immunology (184 citations), Psychiatry and Mental health (104 citations), Neurology (76 citations) and Molecular Biology (373 citations). Debra Tompson has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Christopher Crean, Nicola Scott, Kathleen Weisel, Paul P. Tak, Scott B. Berger, Sarah A. Job, Florian Then Bergh, Richard Grove, Caryl Schwartzbach and Douglas L. Arnold. Their work appears in journals such as Current Clinical Pharmacology, Clinical Therapeutics, British Journal of Clinical Pharmacology, Pharmaceutical Research and Epilepsia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.